AGIO
AGIOS PHARMACEUTICALS, INC.D4915-min delayed · EOD close34.13 −0.23% downas of 2026-09-02mkt cap $2.0B
Pharmaceutical Preparations · SIC 2834 · CIK 0001439222
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $98.3M | 2026-06-30 | 10-Q · 0001439222-26-000118 |
| Revenue (prior year) | $36.5M | 2024-12-31 | 10-K · 0001439222-25-000009 |
| Operating income | −$459M | 2026-06-30 | 10-Q · 0001439222-26-000118 |
| Net income | −$411M | 2026-06-30 | 10-Q · 0001439222-26-000118 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $1.1B | 2026-06-30 | 10-Q · 0001439222-26-000118 |
| Current assets | $718M | 2026-06-30 | 10-Q · 0001439222-26-000118 |
| Total liabilities | $82.4M | 2026-06-30 | 10-Q · 0001439222-26-000118 |